These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

476 related articles for article (PubMed ID: 19059455)

  • 21. Preclinical pharmacokinetics of a novel HIV-1 attachment inhibitor BMS-378806 and prediction of its human pharmacokinetics.
    Yang Z; Zadjura L; D'Arienzo C; Marino A; Santone K; Klunk L; Greene D; Lin PF; Colonno R; Wang T; Meanwell N; Hansel S
    Biopharm Drug Dispos; 2005 Dec; 26(9):387-402. PubMed ID: 16142720
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Metabolism, distribution, and excretion of a next generation selective estrogen receptor modulator, lasofoxifene, in rats and monkeys.
    Prakash C; Johnson KA; Schroeder CM; Potchoiba MJ
    Drug Metab Dispos; 2008 Sep; 36(9):1753-69. PubMed ID: 18515329
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacokinetics and metabolism in rats, dogs, and monkeys of the cathepsin k inhibitor odanacatib: demethylation of a methylsulfonyl moiety as a major metabolic pathway.
    Kassahun K; Black WC; Nicoll-Griffith D; McIntosh I; Chauret N; Day S; Rosenberg E; Koeplinger K
    Drug Metab Dispos; 2011 Jun; 39(6):1079-87. PubMed ID: 21422190
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Human pharmacokinetic prediction of UDP-glucuronosyltransferase substrates with an animal scale-up approach.
    Deguchi T; Watanabe N; Kurihara A; Igeta K; Ikenaga H; Fusegawa K; Suzuki N; Murata S; Hirouchi M; Furuta Y; Iwasaki M; Okazaki O; Izumi T
    Drug Metab Dispos; 2011 May; 39(5):820-9. PubMed ID: 21282406
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacokinetics of muraglitazar (BMS-298585), a dual peroxisome proliferator-activated receptors (PPAR) alpha and gamma activator, in mice, rats, dogs, and monkeys.
    Hosagrahara VP; Chandrasena G; Chang SY; Koplowitz B; Hariharan N; Cheng PT; Humphreys WG
    Xenobiotica; 2006 Dec; 36(12):1227-38. PubMed ID: 17162469
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacokinetics and fate of 3H-trospectomycin sulphate, a novel aminocyclitol antibiotic, in male and female rats.
    Nichols DJ; Burrows M; Bye A; Constable DA; Dring LG; Jeffrey P
    Xenobiotica; 1991 Jul; 21(7):827-37. PubMed ID: 1837966
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacokinetics of aminomethylpropanol in rats following oral and a novel dermal study design.
    Saghir SA; Clark AJ; McClymont EL; Staley JL
    Food Chem Toxicol; 2008 Feb; 46(2):678-87. PubMed ID: 17961896
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vivo metabolism and final disposition of a novel nonsteroidal androgen in rats and dogs.
    Perera MA; Yin D; Wu D; Chan KK; Miller DD; Dalton J
    Drug Metab Dispos; 2006 Oct; 34(10):1713-21. PubMed ID: 16815963
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacokinetics of a new human monoclonal antibody against cytomegalovirus. Third communication: correspondence of the idiotype activity and virus neutralization activity of the new monoclonal antibody, regavirumab in rat serum and its pharmacokinetics in rats and monkeys.
    Arizono H; Sugano T; Kaida S; Shibusawa K; Karasawa Y; Esumi Y; Kondo S; Kiyoki M
    Arzneimittelforschung; 1994 Jul; 44(7):909-13. PubMed ID: 7945531
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tissue distribution of 35S-labelled perfluorobutanesulfonic acid in adult mice following dietary exposure for 1-5 days.
    Bogdanska J; Sundström M; Bergström U; Borg D; Abedi-Valugerdi M; Bergman Å; DePierre J; Nobel S
    Chemosphere; 2014 Mar; 98():28-36. PubMed ID: 24238775
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Metabolism, pharmacokinetics, and excretion of a cholesteryl ester transfer protein inhibitor, torcetrapib, in rats, monkeys, and mice: characterization of unusual and novel metabolites by high-resolution liquid chromatography-tandem mass spectrometry and 1H nuclear magnetic resonance.
    Prakash C; Chen W; Rossulek M; Johnson K; Zhang C; O'Connell T; Potchoiba M; Dalvie D
    Drug Metab Dispos; 2008 Oct; 36(10):2064-79. PubMed ID: 18653742
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Single-dose pharmacokinetics and metabolism of [14C]remofovir in rats and cynomolgus monkeys.
    Lin CC; Xu C; Zhu N; Lourenco D; Yeh LT
    Antimicrob Agents Chemother; 2005 Mar; 49(3):925-30. PubMed ID: 15728885
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Preclinical pharmacokinetics, interspecies scaling, and tissue distribution of humanized monoclonal anti-IL-13 antibodies with different IL-13 neutralization mechanisms.
    Vugmeyster Y; Szklut P; Tchistiakova L; Abraham W; Kasaian M; Xu X
    Int Immunopharmacol; 2008 Mar; 8(3):477-83. PubMed ID: 18279802
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dose-dependent pharmacokinetics of 1-(2-deoxy-beta-D- ribofuranosyl)-2,4-difluoro-5-iodobenzene: a potential mimic of 5-iodo-2'-deoxyuridine.
    Khalili P; Naimi E; Sun WY; Knaus EE; Wiebe LI
    Biopharm Drug Dispos; 2003 Dec; 24(9):385-95. PubMed ID: 14689467
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of the pharmacokinetics of moxidectin and ivermectin after oral administration to beagle dogs.
    Al-Azzam SI; Fleckenstein L; Cheng KJ; Dzimianski MT; McCall JW
    Biopharm Drug Dispos; 2007 Nov; 28(8):431-8. PubMed ID: 17847063
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacokinetics of florfenicol and its metabolite, florfenicol amine, in dogs.
    Park BK; Lim JH; Kim MS; Hwang YH; Yun HI
    Res Vet Sci; 2008 Feb; 84(1):85-9. PubMed ID: 17570454
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacokinetics and bioavailability of diisopropanolamine (DIPA) in rats following intravenous or dermal application.
    Saghir SA; Frantz SW; Spence MW; Nolan RJ; Lowe ER; Rick DL; Bartels MJ
    Food Chem Toxicol; 2007 Oct; 45(10):2047-56. PubMed ID: 17583405
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nonlinear oral pharmacokinetics of the alpha-antagonist 4-amino-5-(4-fluorophenyl)-6,7-dimethoxy-2-[4-(morpholinocarbonyl)-perhydro-1,4-diazepin-1-yl]quinoline in humans: use of preclinical data to rationalize clinical observations.
    Harrison A; Betts A; Fenner K; Beaumont K; Edgington A; Roffey S; Davis J; Comby P; Morgan P
    Drug Metab Dispos; 2004 Feb; 32(2):197-204. PubMed ID: 14744941
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacokinetics of ketoprofen enantiomers in monkeys following single and multiple oral administration.
    Mauleon D; Mis R; Ginesta J; Ortega E; Vilageliu J; Basi N; Carganico G
    Chirality; 1994; 6(7):537-42. PubMed ID: 7986668
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Absorption and elimination of D and C Red No. 28 in male F-344 rats.
    Sweet CJ; Sólyom AM; Sipes IG
    Food Chem Toxicol; 2004 Apr; 42(4):641-8. PubMed ID: 15019189
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.